ReLive Biotechnologies, Ltd. Completes Asset Purchase of Co.Don AG and Series A Financing Led By SHC, Furthering its Ambition to Become the Global Leader in Regenerative Therapies
- Written by PR Newswire
NANJING, China, Jan. 26, 2023 /PRNewswire/ -- As the tissue engineering and regenerative medicine industry has shown tremendous potential in clinical practices in recent years worldwide, China's blue ocean market welcomes the first wave of acquisitions.
ReLive Biotechnologies, Ltd. ("ReLive" or "Company", a leading industry player, announces it has...
